Combined oral and parenteral iron chelation in beta thalassaemia major

Medical Journal of Malaysia

Volumn 55, Issue 4, 2000, Pages 493-497

  Balveer, K ^a   Pyar, K ^a   Wonke, B ^a  

^a HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Deferiprone; Desferrioxamine; Iron chelation; Thalassaemia

Indexed keywords

ALANINE AMINOTRANSFERASE; DEFERIPRONE; DEFEROXAMINE; FERRITIN; STEROID;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COST; DRUG INDUCED DISEASE; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; IRON CHELATION; IRON OVERLOAD; LIVER METABOLISM; MALE; NAUSEA; RASH; THALASSEMIA; TREATMENT OUTCOME; URINARY EXCRETION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; DEFEROXAMINE; DRUG THERAPY, COMBINATION; FEMALE; FERRITINS; HUMANS; INJECTIONS, SUBCUTANEOUS; IRON; IRON CHELATING AGENTS; LIVER; MALE; PYRIDONES;

EID: 0034491797     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Thalassaemia as a community problem in South East Asia
2. The clinical severity of beta thalassaemia major mutations in West Malaysia
3. Survival and causes of death in thalassaemia major
4. Recommendation for transfusion treatment of beta thalassaemia major
5. Iron-chelation therapy with oral deferiprone in patients with thalassaemia major
6. Long term trial with the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1): Clinical observations
7. Long term assessment of efficacy and safety of L1 an oral iron chelator in transfusion-dependent thalasseamia: Indian trial
8. Combined therapy with deferiprone and desferrioxamine
9. Oral iron chelation: A potential role for HBED in combined therapy
10. Thalassaemia
11. Deferiprone Trial in Thalassaemia: Experience from Thailand